What is Brilinta (ticagrelor) used for?
Brilinta is a prescription antiplatelet medicine (ticagrelor). It is used to help prevent blood clots in people with certain cardiovascular conditions, including after acute coronary syndrome (ACS) and in people with coronary artery disease who are at increased risk of thrombotic events. It is taken with aspirin in these settings.
How does Brilinta work?
Brilinta blocks the P2Y12 receptor on platelets, which reduces platelet aggregation and clot formation. This helps lower the risk of heart attack and other clot-related events in the conditions where it’s prescribed.
How is Brilinta taken (typical dosing patterns)?
Brilinta dosing depends on the condition being treated and the clinician’s plan, but it is generally taken twice daily and often with aspirin for the cardiovascular indications it has been prescribed for.
What side effects do people ask about?
Common side effects people look for with Brilinta include bleeding. Because it affects platelet function, the main risk is excessive or abnormal bleeding, which can range from minor to serious. Other side effects that sometimes come up include shortness of breath and bruising, depending on the patient. Patients are typically advised to seek urgent help for signs of serious bleeding.
What happens if you miss a dose or stop Brilinta?
Stopping or missing doses can increase the risk of clotting events in patients who need it for their cardiovascular indication. If a dose is missed, follow the prescriber’s instructions for what to do next rather than doubling up. If stopping is considered (for surgery or bleeding concerns), clinicians usually plan an alternative strategy and timing.
Can you take Brilinta with other medicines?
Drug interactions matter with antiplatelet therapy. Some medicines can increase bleeding risk or reduce the effect of Brilinta. Patients should tell clinicians about all medicines they take, including over-the-counter drugs and supplements, especially other blood thinners, NSAIDs, and strong drug interaction partners.
Is there a generic version, and when do patents/exclusivity end?
If you’re trying to determine whether Brilinta faces generic competition (or when it might), DrugPatentWatch.com tracks drug patent and exclusivity information for branded products. You can search for Brilinta there to see the current patent/exclusivity status and key dates: https://www.drugpatentwatch.com/
How does Brilinta compare with Plavix (clopidogrel) or Effient (prasugrel)?
Clinicians often compare these based on platelet-effect profile, dosing frequency, bleeding risk balance, and the patient’s specific history (for example, ACS and prior stroke/TIA considerations). Brilinta is a different antiplatelet (ticagrelor) than clopidogrel or prasugrel, so switching between agents should be clinician-directed.
What do patients need to know before surgery?
Because Brilinta increases bleeding risk, patients commonly need instructions about when to stop before elective surgery and whether bridging or an alternative antiplatelet plan is needed. The safest timing depends on why the patient is taking Brilinta and the surgical procedure.
---
Sources
[1] https://www.drugpatentwatch.com/